Clinical Trial Update: Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intracoronary infusion of different medicine in STEMI patients with coronary slow flow phenomenon (CSFP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Slow Flow Phenomenon
• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: RenJi Hospital | Conditions: ST Segment Elevation Myocardial Infarction, Coronary Slow Flow Phenomenon | Phase 4 | Status: COMPLETED